Fermentation & Cell Culture
The quality of starting materials resulting from Fermentation Scale Up often determine the purification strategy or even the success of purification. Our Cell Culture Services aim at achieving maximal r-protein production through optimization of fermentation processes and it could be a very important purification step in itself. Time and effort invested at this stage often result in substantially shorter purification protocols and higher yields of active r-protein. Our experience with various high-producing cell lines, cell culture growth modes, media formulations, methods of protein extraction, fractionation and enrichment enables us to design the most optimal production process for your starting materials.Request a Quote
LARGE SCALE PLASMID DNA PREPARATION
LARGE SCALE PROTEIN PRODUCTION
- clarified conditioned media from mammalian, yeast and insect cells
- mammalian cell pellet
- insect cell paste
- bacterial paste
- yeast paste
- transient transfection into mammalian cells
- infection of insect cells with high-titer baculovirus
- propagation of stably-expressing insect or mammalian cells
- suspension cell line growth in shake flasks and Wave bioreactors
- adherent cell line growth in multifloor flasks and cell factories
CELL LYSIS OPTIONS
- detergent solubilization
- hypotonic solution treatment
- combination of the above
INCLUSION BODIES REFOLDING SCREEN
TARGET PROTEIN ENRICHMENT BY
- ammonium sulfate precipitation
- sucrose gradient centrifugation
- differential detergent extraction
- partition into Triton X-114
- treatment for membrane preparations
- inclusion bodies isolation, wash, solubilization and refolding
CONCENTRATION AND BUFFER EXCHANGE OF CONDITIONED MEDIA BY
- tangential flow filtration (TFF)
QUANTITATIVE ANALYSIS OF THE TARGET PROTEIN EXPRESSION
Useful Tools for a Fermentation & Cell Culture ProjectHemocytometer Calculator
Transfection Protocol Calculator
E. coli Cell Culture Concentration from OD600 Formula
Selected Latest Developments in Fermentation & Cell Culture
Recombinant protein production associated growth inhibition results mainly from transcription and not from translation.Zhaopeng Li & Ursula Rinas, Microb Cell Fact, 2020 Apr 6;19(1):83.
Background: Recombinant protein production can be stressful to the host organism. The extent of stress is determined by the specific properties of the recombinant transcript and protein, by the rates of transcription and translation, and by the environmental conditions encountered during the production process.
Results: The impact of the transcription of the T7-promoter controlled genes encoding human basic fibroblast growth factor (hFGF-2) and green fluorescent protein (GFP) as well as the translation into the recombinant protein on the growth properties of the production host E. coli BL21(DE3) were investigated. This was done by using expression vectors where the promoter region or the ribosome binding site(s) or both were removed. It is shown that already transcription without protein translation imposes a metabolic burden on the host cell. Translation of the transcript into large amounts of a properly folded protein does not show any effect on cell growth in the best case, e.g. high-level production of GFP in Luria-Bertani medium. However, translation appears to contribute to the metabolic burden if it is connected to protein folding associated problems, e.g. inclusion body formation.
Influence of cytoskeleton organization on recombinant protein expression by CHO cellsLucille Pourcel et al., Biotechnol Bioeng. 2020 Apr; 117(4): 1117–1126.
In this study, we assessed the importance of cytoskeleton organization in the mammalian cells used to produce therapeutic proteins. Two cytoskeletal genes, Actin alpha cardiac muscle 1 (ACTC1) and a guanosine triphosphate GTPase‐activating protein (TAGAP), were found to be upregulated in highly productive therapeutic protein‐expressing Chinese hamster ovary (CHO) cells selected by the deprivation of vitamin B5. We report here that the overexpression of the ACTC1 protein was able to improve significantly recombinant therapeutic production, as well as to decrease the levels of toxic lactate metabolic by‐products. ACTC1 overexpression was accompanied by altered as well as decreased polymerized actin, which was associated with high protein production by CHO cell cultured in suspension. We suggest that the depolymerization of actin and the possible modulation of integrin signaling, as well as changes in basal metabolism, may be driving the increase of protein secretion by CHO cells.
Evolution from adherent to suspension: systems biology of HEK293 cell line developmentMagdalena Malm et al., Sci Rep. 2020; 10: 18996.
The need for new safe and efficacious therapies has led to an increased focus on biologics produced in mammalian cells. The human cell line HEK293 has bio-synthetic potential for human-like production attributes and is currently used for manufacturing of several therapeutic proteins and viral vectors. Despite the increased popularity of this strain we still have limited knowledge on the genetic composition of its derivatives. Here we present a genomic, transcriptomic and metabolic gene analysis of six of the most widely used HEK293 cell lines. Changes in gene copy and expression between industrial progeny cell lines and the original HEK293 were associated with cellular component organization, cell motility and cell adhesion. Changes in gene expression between adherent and suspension derivatives highlighted switching in cholesterol biosynthesis and expression of five key genes (RARG, ID1, ZIC1, LOX and DHRS3), a pattern validated in 63 human adherent or suspension cell lines of other origin.